Viewing data from:

PILOCARPINE HYDROCHLORIDE

ANDA

PILOCARPINE HYDROCHLORIDE | A077220 | LANNETT CO INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: SALAGEN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.3154

per ea

Lowest NADAC/Unit

$0.3028

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00527131301PILOCARPINE HCL 5 MG TABLET	$0.3154	EA	Generic	—	2026-06-17
50268065212PILOCARPINE HCL 5 MG TABLET	$0.3154	EA	Generic	—	2026-06-17
00527140701PILOCARPINE HCL 7.5 MG TABLET	$0.3028	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$31.85

Highest Price

$50.75

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00527-1313-01PILOCARPINE HCL 5MG TAB	$31.85	FSS	AvKare, LLC	06/14/2028
00527-1407-01PILOCARPINE HCL 7.5MG TAB	$50.75	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs4 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

ANIDRO DO BRASIL EXTRACOES SAPILOCARPINE HYDROCHLORIDE USP

DMF 100251992

SPERA NEXUS INCPILOCARPINE HYDROCHLORIDE

DMF 123881997

SOURCETECH QUIMICA LTDAPILOCARPINE HYDROCHLORIDE

DMF 168732003

ZHEJIANG AUSUN PHARMACEUTICAL CO LTDPILOCARPINE HYDROCHLORIDE

DMF 389012023

LINNEA PHYTOCHEMICALSInactivePILOCARPINE HYDROCHLORIDE

DMF 75361988

ANIDRO DO BRASIL EXTRACOES SAInactivePILOCARPINE HYDROCHLORIDE

DMF 84531990

BOEHRINGER INGELHEIM PHARMA KGInactivePILOCARPINE HYDROCHLORIDE

DMF 93321991

PVP SOCIEDADE ANONIMAInactivePILOCARPINE HYDROCHLORIDE

DMF 108611994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 14, 2005

No patent or exclusivity listings for this strength.

#002 — 7.5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 6, 2009